Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis

Georgakopoulou,Vasiliki Epameinondas; Spandidos,Demetrios A.; Papalexis,Petros; Gkoufa,Aikaterini; Aravantinou‑Fatorou,Aikaterini; Angelopoulou,Efthalia; Trakas,Ilias; Trakas,Nikolaos; Fotakopoulos,George

doi:10.3892/etm.2023.11992

Outcomes in meningitis‑ventriculitis treated with intravenous or intrathecal plus intravenous colistin: A meta‑analysis

Authors:
- Vasiliki Epameinondas Georgakopoulou
- Demetrios A. Spandidos
- Petros Papalexis
- Aikaterini Gkoufa
- Aikaterini Aravantinou‑Fatorou
- Efthalia Angelopoulou
- Ilias Trakas
- Nikolaos Trakas
- George Fotakopoulos
View Affiliations

Affiliations: Department of Infectious Diseases and COVID‑19 Unit, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece, Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece, Unit of Endocrinology, First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece, First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece, Department of Neurology, Aiginition University Hospital, National and Kapodistrian University of Athens, 11528 Athens, Greece, Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece, Department of Neurosurgery, General University Hospital of Larissa, 41221 Larissa, Greece
Published online on: May 4, 2023 https://doi.org/10.3892/etm.2023.11992
Article Number: 293
Copyright: © Georgakopoulou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present meta‑analysis was to provide further evidence on the management of bacterial ventriculitis or meningitis (BVM) and to compare the efficacy of intravenous (IV) or intravenous plus intrathecal (IV/ITH) treatment with colistin. The present meta‑analysis included full‑text articles published between 1980 and 2020 that compared outcomes in meningitis‑ventriculitis treated with IV or IV/ITH colistin. The collected variables included the first author's name, country, study period covered, publication year, the total number of patients and follow‑up, Glasgow Coma Scale score upon admission, treatment duration, Acute Physiological and Chronic Health Evaluation II score, the length of intensive unit (ICU) stay, treatment efficacy and mortality for both groups. To avoid publication bias, the final aim was to collect a homogenous pool of manuscripts, including only articles that compared only two modalities. After applying all exclusion and inclusion criteria, seven of 55 articles were left in the final article pool. The total number of patients in those seven articles was 293, divided into two groups (186 in the IV and 107 in the IV/ITH group). As regards ICU stay and mortality, the findings illustrated a statistically significant difference between the two groups. On the whole, the findings of the present study support the addition of ITH colistin to its IV administration for the effective treatment of BVM.

View Figures

View References

1	Berk SL and McCabe WR: Meningitis caused by gram-negative bacilli. Ann Intern Med. 93:253–260. 1980.PubMed/NCBI View Article : Google Scholar
2	Camacho EF, Boszczowski I, Basso M, Jeng BC, Freire MP, Guimarães T, Teixeira MJ and Costa SF: Infection rate and risk factors associated with infections related to external ventricular drain. Infection. 39:47–51. 2011.PubMed/NCBI View Article : Google Scholar
3	Cascio A, Conti A, Sinardi L, Iaria C, Angileri FF, Stassi G, David T, Versaci A, Iaria M and David A: Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature. Int J Infect Dis. 14:e572–e579. 2010.PubMed/NCBI View Article : Google Scholar
4	Faillace WJ: A no-touch technique protocol to diminish cerebrospinal fluid shunt infection. Surg Neurol. 43:344–350. 1995.PubMed/NCBI View Article : Google Scholar
5	Tsolaki V, Karvouniaris M, Manoulakas E, Kotlia P, Karadontas V, Fotakopoulos G, Zakynthinos E and Makris D: Intraventricular CNS treatment with colistin-tigecycline combination: A case series. J Crit Care. 47:338–341. 2018.PubMed/NCBI View Article : Google Scholar
6	Laxmi S and Tunkel AR: Healthcare-associated bacterial meningitis. Curr Infect Dis Rep. 13:367–373. 2011.PubMed/NCBI View Article : Google Scholar
7	Stenehjem E and Armstrong WS: Central nervous system device infections. Infect Dis Clin North Am. 26:89–110. 2012.PubMed/NCBI View Article : Google Scholar
8	Parodi S, Lechner A, Osih R, Vespa P and Pegues D: Nosocomial enterobacter meningitis: Risk factors, management, and treatment outcomes. Clin Infect Dis. 37:159–166. 2003.PubMed/NCBI View Article : Google Scholar
9	Falagas ME and Kasiakou SK: Toxicity of polymyxins: A systematic review of the evidence from old and recent studies. Crit Care. 10(R27)2006.PubMed/NCBI View Article : Google Scholar
10	Baiocchi M, Catena V, Zago S, Badolati L and Baccarin M: Intrathecal colistin for treatment of multidrug resistant (MDR) Pseudomonas aeruginosa after neurosurgical ventriculitis. Infez Med. 18:182–186. 2010.PubMed/NCBI
11	Fotakopoulos G, Makris D, Chatzi M, Tsimitrea E, Zakynthinos E and Fountas K: Outcomes in meningitis/ventriculitis treated with intravenous or intraventricular plus intravenous colistin. Acta Neurochir (Wien). 158:603–610; discussion 610. 2016.PubMed/NCBI View Article : Google Scholar
12	Foster RL: Reporting guidelines: CONSORT, PRISMA, and SQUIRE. J Spec Pediatr Nurs. 17:1–2. 2012.PubMed/NCBI View Article : Google Scholar
13	Bae JM: A suggestion for quality assessment in systematic reviews of observational studies in nutritional epidemiology. Epidemiol Health. 38(e2016014)2016.PubMed/NCBI View Article : Google Scholar
14	Chusri S, Sakarunchai I, Kositpantawong N, Panthuwong S, Santimaleeworagun W, Pattharachayakul S, Singkhamanan K and Doi Y: Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii. Int J Antimicrob Agents. 51:646–650. 2018.PubMed/NCBI View Article : Google Scholar
15	Shofty B, Neuberger A, Naffaa ME, Binawi T, Babitch T, Rappaport ZH, Zaaroor M, Sviri G and Paul M: Intrathecal or intraventricular therapy for post-neurosurgical gram-negative meningitis: Matched cohort study. Clin Microbiol Infect. 22:66–70. 2016.PubMed/NCBI View Article : Google Scholar
16	De Bonis P, Lofrese G, Scoppettuolo G, Spanu T, Cultrera R, Labonia M, Cavallo MA, Mangiola A, Anile C and Pompucci A: Intraventricular versus intravenous colistin for the treatment of extensively drug resistant acinetobacter baumannii meningitis. Eur J Neurol. 23:68–75. 2016.PubMed/NCBI View Article : Google Scholar
17	Moon C, Kwak YG, Kim BN, Kim ES and Lee CS: Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii. J Infect Chemother. 19:916–919. 2013.PubMed/NCBI View Article : Google Scholar
18	Wang JH, Lin PC, Chou CH, Ho CM, Lin KH, Tsai CT, Wang JH, Chi CY and Ho MW: Intraventricular antimicrobial therapy in postneurosurgical gram-negative bacillary meningitis or ventriculitis: A hospital-based retrospective study. J Microbiol Immunol Infect. 47:204–210. 2014.PubMed/NCBI View Article : Google Scholar
19	Tängdén T, Enblad P, Ullberg M and Sjölin J: Neurosurgical gram-negative bacillary ventriculitis and meningitis: A retrospective study evaluating the efficacy of intraventricular gentamicin therapy in 31 consecutive cases. Clin Infect Dis. 52:1310–1316. 2011.PubMed/NCBI View Article : Google Scholar
20	Ziaka M, Markantonis SL, Fousteri M, Zygoulis P, Panidis D, Karvouniaris M, Makris D and Zakynthinos E: Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection. Antimicrob Agents Chemother. 57:1938–1940. 2013.PubMed/NCBI View Article : Google Scholar
21	Koch-Weser J, Sidel VW, Federman EB, Kanarek P, Finer DC and Eaton AE: Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann Intern Med. 72:857–868. 1970.PubMed/NCBI View Article : Google Scholar
22	Li J, Nation RL, Turnidge JD, Milne RW, Coulthard K, Rayner CR and Paterson DL: Colistin: The re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections. Lancet Infect Dis. 6:589–601. 2006.PubMed/NCBI View Article : Google Scholar
23	Vicari G, Bauer SR, Neuner EA and Lam SW: Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia. Clin Infect Dis. 56:398–404. 2013.PubMed/NCBI View Article : Google Scholar